NBPF6
gene geneOn this page
Summary
NBPF6 (NBPF member 6, HGNC:31988) is a protein-coding gene on chromosome 1p13.3, encoding NBPF family member NBPF6 (Q5VWK0).
This gene is a member of the neuroblastoma breakpoint family (NBPF) which consists of dozens of recently duplicated genes primarily located in segmental duplications on human chromosome 1. This gene family has experienced its greatest expansion within the human lineage and has expanded, to a lesser extent, among primates in general. Members of this gene family are characterized by tandemly repeated copies of DUF1220 protein domains. Gene copy number variations in the human chromosomal region 1q21.1, where most DUF1220 domains are located, have been implicated in a number of developmental and neurogenetic diseases such as microcephaly, macrocephaly, autism, schizophrenia, cognitive disability, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies. Altered expression of some gene family members is associated with several types of cancer. This gene family contains numerous pseudogenes. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms.
Source: NCBI Gene 653149 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 49 total
- MANE Select transcript:
NM_001143988
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31988 |
| Approved symbol | NBPF6 |
| Name | NBPF member 6 |
| Location | 1p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000186086 |
| Ensembl biotype | protein_coding |
| OMIM | 613996 |
| Entrez | 653149 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000370040, ENST00000495380, ENST00000531446
RefSeq mRNA: 2 — MANE Select: NM_001143988
NM_001143987, NM_001143988
CCDS: CCDS44184
Canonical transcript exons
ENST00000495380 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001600935 | 108453181 | 108453395 |
| ENSE00001658235 | 108454439 | 108454517 |
| ENSE00001752745 | 108452190 | 108452289 |
| ENSE00001805673 | 108450567 | 108450779 |
| ENSE00002194019 | 108450343 | 108450464 |
| ENSE00003718394 | 108467451 | 108467665 |
| ENSE00003721351 | 108459058 | 108459109 |
| ENSE00003726919 | 108465188 | 108465424 |
| ENSE00003731993 | 108470597 | 108471920 |
| ENSE00003732117 | 108461133 | 108461184 |
| ENSE00003739926 | 108457007 | 108457058 |
| ENSE00003746343 | 108455386 | 108455597 |
| ENSE00003748451 | 108459933 | 108460102 |
| ENSE00003749312 | 108457936 | 108458075 |
| ENSE00003754657 | 108461916 | 108462088 |
Expression profiles
Bgee: expression breadth broad, 31 present calls, max score 56.44.
Top tissues by expression
110 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| testis | UBERON:0000473 | 56.44 | gold quality |
| left testis | UBERON:0004533 | 55.96 | gold quality |
| right testis | UBERON:0004534 | 54.90 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 51.33 | gold quality |
| placenta | UBERON:0001987 | 50.96 | gold quality |
| small intestine | UBERON:0002108 | 50.14 | gold quality |
| adenohypophysis | UBERON:0002196 | 47.22 | gold quality |
| pituitary gland | UBERON:0000007 | 47.03 | gold quality |
| putamen | UBERON:0001874 | 46.82 | gold quality |
| duodenum | UBERON:0002114 | 45.30 | gold quality |
| rectum | UBERON:0001052 | 45.02 | gold quality |
| tibial artery | UBERON:0007610 | 43.35 | gold quality |
| popliteal artery | UBERON:0002250 | 43.34 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.59 | gold quality |
| caudate nucleus | UBERON:0001873 | 41.39 | gold quality |
| right coronary artery | UBERON:0001625 | 40.92 | silver quality |
| gall bladder | UBERON:0002110 | 39.50 | silver quality |
| right adrenal gland cortex | UBERON:0035827 | 38.46 | silver quality |
| lymph node | UBERON:0000029 | 37.40 | gold quality |
| tonsil | UBERON:0002372 | 37.06 | silver quality |
| monocyte | CL:0000576 | 37.00 | silver quality |
| left coronary artery | UBERON:0001626 | 36.92 | gold quality |
| leukocyte | CL:0000738 | 36.75 | silver quality |
| prefrontal cortex | UBERON:0000451 | 36.67 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 36.11 | gold quality |
| intestine | UBERON:0000160 | 35.67 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.82 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (14): NBPF3 (ENSG00000142794), NBPF20 (ENSG00000162825), NBPF4 (ENSG00000196427), NBPF1 (ENSG00000219481), NBPF11 (ENSG00000263956), NBPF15 (ENSG00000266338), NBPF12 (ENSG00000268043), NBPF9 (ENSG00000269713), NBPF8 (ENSG00000270231), NBPF14 (ENSG00000270629), (ENSG00000271254), NBPF19 (ENSG00000271383), NBPF10 (ENSG00000271425), NBPF26 (ENSG00000273136)
Protein
Protein identifiers
NBPF family member NBPF6 — Q5VWK0 (reviewed: Q5VWK0)
Alternative names: Neuroblastoma breakpoint family member 6
All UniProt accessions (2): A0A0B4J227, Q5VWK0
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm.
Miscellaneous. Encoded by one of the numerous copies of NBPF genes clustered in the p36, p12 and q21 region of the chromosome 1.
Similarity. Belongs to the NBPF family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5VWK0-1 | 1 | yes |
| Q5VWK0-2 | 2 |
RefSeq proteins (2): NP_001137459, NP_001137460* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010630 | Olduvai_dom | Domain |
| IPR055306 | NBPF | Family |
Pfam: PF06758
UniProt features (14 total): compositionally biased region 5, domain 3, region of interest 2, coiled-coil region 2, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VWK0-F1 | 51.18 | 0.07 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 1 (showing top):
chr1p13
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
314 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NBPF6 | PROX2 | Q3B8N5 | 447 |
| NBPF6 | TMTC2 | Q8N394 | 350 |
| NBPF6 | EXOC3L2 | Q2M3D2 | 344 |
| NBPF6 | USP42 | Q9H9J4 | 333 |
| NBPF6 | PLEKHM3 | Q6ZWE6 | 326 |
| NBPF6 | FPGT | O14772 | 324 |
| NBPF6 | MINPP1 | Q9UNW1 | 323 |
| NBPF6 | B3GLCT | Q6Y288 | 319 |
| NBPF6 | SLC25A24 | Q6NUK1 | 303 |
| NBPF6 | BRINP1 | O60477 | 292 |
| NBPF6 | NOTCH2NLB | P0DPK3 | 290 |
| NBPF6 | BEND3 | Q5T5X7 | 289 |
| NBPF6 | PSRC1 | Q6PGN9 | 267 |
| NBPF6 | MARK4 | Q96L34 | 263 |
| NBPF6 | SEMA6D | Q8NFY4 | 233 |
IntAct
0 interactions, top by confidence:
BioGRID (5): NBPF6 (Affinity Capture-RNA), NBPF6 (Two-hybrid), NBPF6 (Two-hybrid), NBPF6 (Two-hybrid), AQP1 (Two-hybrid)
ESM2 similar proteins: A0A1B0GTH6, A0A1B0GUW6, A0A1D5RMD1, A2AQH4, A4FU49, A6NJ88, C4P6S0, D3YU32, E9PAV3, F1QU13, I3L273, J3KML8, P70670, Q32L62, Q3V0E1, Q3V3Q4, Q4R729, Q5H9F3, Q5QJ38, Q5SWP3, Q5U4C1, Q5VWK0, Q5VYM1, Q68DN1, Q6AZ54, Q7TSG5, Q810T2, Q8CH19, Q8K4E0, Q8N3K9, Q8N5Q1, Q8NDH2, Q8TCU4, Q8WNU4, Q8WWL7, Q920R4, Q921B4, Q923B3, Q96JA4, Q96M34
Diamond homologs: A0A087WUL8, B4DH59, P0C2Y1, P0DPF2, P0DPF3, Q32LC2, Q3BBV0, Q3BBV2, Q5TAG4, Q5TI25, Q5VU43, Q5VWK0, Q6P3W6, Q86T75, Q86XG9, Q8N660, Q96M43, Q9H094, A0A096LNW5, A2RUV0, G3I6Z6, O35516, P0DPK3, P0DPK4, P10040, P21783, P46530, P46531, Q01705, Q04721, Q04756, Q07008, Q20911, Q7Z3S9, Q80YT7, Q99466, Q9QW30, Q9UM47, Q19UN5, Q8K389
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
49 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 42 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2303 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:108450465:G:GG | donor_gain | 1.0000 |
| 1:108450775:ATACA:A | donor_gain | 1.0000 |
| 1:108450776:TACA:T | donor_gain | 1.0000 |
| 1:108450778:CA:C | donor_gain | 1.0000 |
| 1:108450779:AG:A | donor_loss | 1.0000 |
| 1:108450780:G:GG | donor_gain | 1.0000 |
| 1:108450780:G:T | donor_loss | 1.0000 |
| 1:108450781:T:A | donor_loss | 1.0000 |
| 1:108452188:A:AG | acceptor_gain | 1.0000 |
| 1:108452189:G:GA | acceptor_gain | 1.0000 |
| 1:108452189:GA:G | acceptor_gain | 1.0000 |
| 1:108452189:GAGT:G | acceptor_gain | 1.0000 |
| 1:108452273:C:T | donor_gain | 1.0000 |
| 1:108452287:CAGG:C | donor_loss | 1.0000 |
| 1:108452289:GGTG:G | donor_loss | 1.0000 |
| 1:108452291:T:A | donor_loss | 1.0000 |
| 1:108453180:GGCA:G | acceptor_gain | 1.0000 |
| 1:108454435:GCAGA:G | acceptor_loss | 1.0000 |
| 1:108454436:CA:C | acceptor_loss | 1.0000 |
| 1:108454437:A:AC | acceptor_loss | 1.0000 |
| 1:108454437:A:AG | acceptor_gain | 1.0000 |
| 1:108454438:G:GC | acceptor_gain | 1.0000 |
| 1:108454438:GA:G | acceptor_gain | 1.0000 |
| 1:108454438:GAA:G | acceptor_gain | 1.0000 |
| 1:108454438:GAAA:G | acceptor_gain | 1.0000 |
| 1:108454438:GAAAA:G | acceptor_gain | 1.0000 |
| 1:108454483:G:GT | donor_gain | 1.0000 |
| 1:108454501:G:GT | donor_gain | 1.0000 |
| 1:108454516:AG:A | donor_loss | 1.0000 |
| 1:108454517:GGTAA:G | donor_loss | 1.0000 |
AlphaMissense
4212 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:108450740:G:C | A47P | 0.974 |
| 1:108450768:T:C | L56P | 0.970 |
| 1:108453219:T:C | L106P | 0.967 |
| 1:108450758:G:C | A53P | 0.965 |
| 1:108450756:T:C | L52P | 0.956 |
| 1:108453209:G:C | A103P | 0.948 |
| 1:108450725:T:C | F42L | 0.946 |
| 1:108450727:C:A | F42L | 0.946 |
| 1:108450727:C:G | F42L | 0.946 |
| 1:108453270:T:C | L123P | 0.937 |
| 1:108450729:T:C | L43P | 0.935 |
| 1:108453248:G:T | G116W | 0.935 |
| 1:108450704:T:C | F35L | 0.934 |
| 1:108450706:C:A | F35L | 0.934 |
| 1:108450706:C:G | F35L | 0.934 |
| 1:108453365:G:C | A155P | 0.934 |
| 1:108450714:T:C | L38P | 0.933 |
| 1:108453231:G:C | R110P | 0.931 |
| 1:108450746:G:C | A49P | 0.930 |
| 1:108453353:G:A | G151R | 0.924 |
| 1:108453353:G:C | G151R | 0.924 |
| 1:108450738:A:C | Q46P | 0.923 |
| 1:108450765:A:C | Q55P | 0.922 |
| 1:108450684:T:C | L28P | 0.918 |
| 1:108453375:T:C | L158P | 0.918 |
| 1:108453248:G:A | G116R | 0.915 |
| 1:108453248:G:C | G116R | 0.915 |
| 1:108453228:T:C | L109S | 0.914 |
| 1:108453345:T:C | L148P | 0.910 |
| 1:108450708:G:C | R36P | 0.909 |
dbSNP variants (sampled 300 via entrez): RS1000848170 (1:108471508 A>G,T), RS1000983412 (1:108471320 G>A), RS1001100531 (1:108436310 T>C,G), RS1001526919 (1:108438012 A>T), RS1001772989 (1:108464554 T>C), RS1001902875 (1:108222483 T>G), RS1001914967 (1:108472277 CTA>C), RS1002127969 (1:108448548 C>T), RS1002500246 (1:108447746 C>A,T), RS1002720744 (1:108468964 C>T), RS1002800800 (1:108469321 T>G), RS1003598444 (1:108425556 A>C,G), RS1004991481 (1:108460855 G>T), RS1005098118 (1:108459438 T>C), RS1005309929 (1:108429599 G>A,C)
Disease associations
OMIM: gene MIM:613996 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| Cadmium | decreases expression | 1 |
| Cyclosporine | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.